Your browser doesn't support javascript.
loading
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents.
Jantarabenjakul, Watsamon; Anugulruengkitt, Suvaporn; Kasipong, Naruporn; Thammajaruk, Narukjaporn; Sophonphan, Jiratchaya; Bunupuradah, Torsak; Cressey, Tim R; Colbers, Angela; Burger, David M; Phongsamart, Wanatpreeya; Puthanakit, Thanyawee; Pancharoen, Chitsanu.
Afiliação
  • Jantarabenjakul W; Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Anugulruengkitt S; Research Unit in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Kasipong N; Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Thammajaruk N; Research Unit in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Sophonphan J; The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
  • Bunupuradah T; The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
  • Cressey TR; The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
  • Colbers A; Research Unit in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Burger DM; The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
  • Phongsamart W; Program for HIV Prevention and Treatment, Department of Medical Technology, Faculty of Associated Medical Sciences (IRD/174), Chiang Mai University, Chiang Mai, Thailand.
  • Puthanakit T; Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Pancharoen C; Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Antivir Ther ; 23(3): 259-265, 2018.
Article em En | MEDLINE | ID: mdl-28994660
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Rilpivirina Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Antivir Ther Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Rilpivirina Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Antivir Ther Ano de publicação: 2018 Tipo de documento: Article